Abstract
Introduction/aim: Although myotonic dystrophy type 2 (DM2) is generally milder than DM1, quality of life (QoL) seems to be similarly impaired in these two disorders. There are no studies that assessed QoL during DM2. Our aim was to assess QoL and disease outcome in patients with DM2 after a five-year follow-up period. Material and Methods: Study originally comprised 49 DM2 patients at baseline. During the five-year period, seven patients died, eight were lost to follow-up, one patient moved, and one refused testing. The Short Form (36) Health Survey (SF-36) and Individualized Neuromuscular Quality of Life (INQoL) questionnaires were administered in 30 patients at baseline and at follow-up (47% males, 54±10 years old). Results: Patients who were retested had better Role Physical (RP) and General Health (GH) scores of the SF-36 and better weakness score of the INQoL compared to non-retested (p>0.05). After the five-year follow-up, none of the SF-36 and INQoL scores differed compared to baseline (p>0.05). Conclusion: QoL did not change in DM2 patients during a five-year period, as measured by both SF-36 and INQoL.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference20 articles.
1. Rastelli E, Montagnese F, Massa R, Schoser B. Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review. Curr Opin Neurol. 2018; 31(5): 599-609. doi: 10.1097/ WCO.0000000000000591;
2. Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, et al. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med. 2006; 38(3): 181-5. doi: 10.1007/s40271-019-00357-y;
3. Peric S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V, et al. Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg. 2010; 110(1): 71-7;
4. Peric S, Stojanovic VR, Basta I, Peric M, Milicev M, Pavlovic S, Lavrnic D et al. Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg. 2013; 115(3): 270-5. doi: 10.1016/j.clineuro.2012.05.015;
5. Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V, et al. Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg. 2014; 126: 76-81. doi: 10.1016/j.clineuro.2014.08.021;